Cargando…
Novel Diagnostics and Therapeutics in Sepsis
Sepsis management demands early diagnosis and timely treatment that includes source control, antimicrobial therapy, and resuscitation. Currently employed diagnostic tools are ill-equipped to rapidly diagnose sepsis and isolate the offending pathogen, which limits the ability to offer targeted and lo...
Autores principales: | Leong, Kieran, Gaglani, Bhavita, Khanna, Ashish K., McCurdy, Michael T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003067/ https://www.ncbi.nlm.nih.gov/pubmed/33803628 http://dx.doi.org/10.3390/biomedicines9030311 |
Ejemplares similares
-
Sepsis Management in the Cardiac Intensive Care Unit
por: Zhang, Yichi, et al.
Publicado: (2023) -
COVID-19 and the RAAS—a potential role for angiotensin II?
por: Busse, Laurence W., et al.
Publicado: (2020) -
The glycocalyx: a novel diagnostic and therapeutic target in sepsis
por: Uchimido, Ryo, et al.
Publicado: (2019) -
Alpha-1-acid glycoprotein reduces hepatic leukocyte recruitment in early sepsis
por: Fox-Robichaud, A, et al.
Publicado: (2005) -
A novel diagnostic method for a rare fungus: FcMBL facilitates Wickerhamomyces anomalus identification in an immunocompromised neonate
por: Higgins, Conor J., et al.
Publicado: (2023)